CYCC Stock Price | Cyclacel Pharmaceuticals Inc P/E, Revenue, EPS, & Forecasts

Cyclacel Pharmaceuticals Inc • CYCC

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Cyclacel Pharmaceuticals Inc

Ticker

CYCC

Trading on

NASDAQ

ISIN

US23254L6039

Industry

Biotechnology

Sector

Healthcare

CEO

Dr. Sing Ee Wong

Headquarters

Tower 11, Kuala Lumpur, undefined, Malaysia, 59200

Employees

Website

cyclacel.com

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, epigenetics, and mitosis biology in the United States and the United Kingdom. Its lead product, Plogosertib or plogo, is a PLK1 inhibitor, in solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.

Metrics

BasicAdvanced

Market cap

$47.7M

P/E ratio

EPS

-$2.09

Dividend Yield

0.00%

Beta

0.16

Forward P/E ratio

EBIDTA

$-12M

Ex dividend date

Price & volume

Market cap

$47.7M

Average daily volume

0.2M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

1,109.97

Price to book

2.02

Earnings

EPS

-$2.09

EPS estimate (current quarter)

$0.00

EPS estimate (next quarter)

$0.00

EBITDA

$-12M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.01

Technicals

Beta

0.16

52-week High

$4.00

52-week Low

$0.17

50-day moving average

$0.29

200-day moving average

$0.71

Short ratio

0.25

Short %

0.44%

Management effectiveness

ROE (TTM)

807.39%

ROA (TTM)

116.33%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

27,916.28%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

100.00%

Share stats

Outstanding Shares

207M

Float

12.7M

Insiders %

93.93%

Institutions %

0.35%

Analyst Insights & forecasts

0% Buy

100% Hold

0% Sell

Based on information from 1 analysts.

Average price target

$1.00

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$2.27

-$4.74

52.11%

Q1 • 24Beat

-$0.72

-$1.43

49.65%

Q2 • 24Beat

-$0.18

-$0.54

66.67%

Q3 • 24Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-3.1M

∞%

Q4 • 24

$-3.1M

0.00%

Q1 • 25

NaN%

0.00%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$4.1M

$6.3M

153.10%

Q4 • 24

$4.1M

$6.3M

153.10%

Q1 • 25

0.00%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-1.4M

$0M

$1.6M

$-1.4M

Q4 • 24

$-1.4M

$1.6M

$-1.4M

Q1 • 25

0.00%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Cyclacel Pharmaceuticals Inc share?

Cyclacel Pharmaceuticals Inc shares are currently traded for undefined per share.

How many shares does Cyclacel Pharmaceuticals Inc have?

Cyclacel Pharmaceuticals Inc currently has 207M shares.

Does Cyclacel Pharmaceuticals Inc pay dividends?

No, Cyclacel Pharmaceuticals Inc doesn't pay dividends.

What is Cyclacel Pharmaceuticals Inc 52 week high?

Cyclacel Pharmaceuticals Inc 52 week high is $4.00.

What is Cyclacel Pharmaceuticals Inc 52 week low?

Cyclacel Pharmaceuticals Inc 52 week low is $0.17.

What is the 200-day moving average of Cyclacel Pharmaceuticals Inc?

Cyclacel Pharmaceuticals Inc 200-day moving average is $0.71.

Who is Cyclacel Pharmaceuticals Inc CEO?

The CEO of Cyclacel Pharmaceuticals Inc is Dr. Sing Ee Wong.

How many employees Cyclacel Pharmaceuticals Inc has?

Cyclacel Pharmaceuticals Inc has 0 employees.

What is the market cap of Cyclacel Pharmaceuticals Inc?

The market cap of Cyclacel Pharmaceuticals Inc is $47.7M.

What is the P/E of Cyclacel Pharmaceuticals Inc?

The current P/E of Cyclacel Pharmaceuticals Inc is null.

What is the EPS of Cyclacel Pharmaceuticals Inc?

The EPS of Cyclacel Pharmaceuticals Inc is -$2.09.

What is the PEG Ratio of Cyclacel Pharmaceuticals Inc?

The PEG Ratio of Cyclacel Pharmaceuticals Inc is 0.

What do analysts say about Cyclacel Pharmaceuticals Inc?

According to the analysts Cyclacel Pharmaceuticals Inc is considered a hold.